May increase efficacy of GBM treatmentsNon-toxic to healthy cells; reduces comorbiditiesTargets slow-dividing stem cells as opposed to rapid-dividing cells (i.e. chemotherapies)
[更多]
Feature selection and tracking are performed in real-time Improved baseline algorithms in terms of performance accuracy and robustness Lower computational costs
[更多]
|<首頁 <-上一頁 下一頁-> 末頁>| |